Athena Aryannejad
Richmond Hill,ON
Summary
Innovative and results-driven leader with over a decade of pharmaceutical industry experience, excelling in sales, strategic account management, and digital transformation. Demonstrated success in driving revenue growth, building strategic partnerships, and leading high-performance teams. Passionate about leveraging AI and emerging technologies to advance research, optimize healthcare solutions, and deliver meaningful outcomes for patients and stakeholders. Results-driven Sales Manager with proven success in leading sales teams to achieve targets and expand market reach. Skilled in developing effective sales strategies, fostering client relationships, and identifying new business opportunities. Demonstrated ability to improve team performance through coaching and motivational techniques. Consistently enhanced revenue growth by implementing innovative sales tactics and optimizing operational processes.
Overview
15
15
years of professional experience
Work History
National Sales Director
Valeo Pharma
Toronto, Ontario
05.2022 - Current
- Drove Exceptional Growth: Increased revenue from $12.8M (2021-2022) to $17.7M (2022-2023) through strategic planning and execution.
- Market Leadership: Directed a national team of seven Key Account Managers, establishing Redesca as the #1 Enoxaparin biosimilar with a 48% market share in 2023 across several markets, with a 40% growth.
- Collaborative Partnerships: Developed pricing, field strategies, and product execution plans with internal teams, establishing Valeo as a trusted partner for Canadian GPOs, hospitals, and provincial networks.
- RFP Leadership: Led cross-functional execution of RFP bids for specialty products, aligning with business unit objectives, and securing new opportunities.
- Training Excellence: Designed workshops and onboarding programs to enhance Salesforce productivity, covering disease knowledge, product expertise, account management, and digital tools.
- Cross-functional Collaboration: Collaborated with internal stakeholders to create tailored tools, lead advisory board meetings, enhance PSP programs, and develop educational materials, such as speaker decks, and biosimilar marketing resources.
Key Account Manager
Valeo Pharma
Downtown Toronto, Ontario
02.2021 - 05.2022
- Pioneered Market Entry: Successfully launched the first Enoxaparin biosimilar (Redesca) in the low molecular weight heparin market, driving adoption in a competitive landscape.
- Sales Performance & Hospital Listings: Achieved #1 ranking in Ontario hospital sales (2021) by securing multiple hospital formulary listings, overcoming competition through strategic engagement with C-suite executives, P&T committee members, and clinical decision-makers.
- Strategic Execution: Identified key success factors for contract negotiations, operational implementation, and formulary listings, ensuring seamless adoption of Redesca across institutions.
- Digital Optimization Leadership: Implemented company-wide training initiatives to elevate digital engagement and efficiency.
- Redesca Re-labeling Optimization: Led a cross-functional effort to redesign product labels in alignment with GS1 and EMR standards, improving usability and compliance.
Global Learning & Performance Manager
Amgen Canada
Toronto, Ontario
03.2020 - 02.2021
- New Hire Onboarding and National Sales Meeting Trainer.
- Product Launch Meetings: Biosimilars - KANJINTI (Trastuzumab) and AVSOLA (Infliximab) co-support.
- Ongoing Training Programs: Performance 4 Workshops, Aranesp Retraining Program.
- Global Learning Initiatives: Integration of Webex Virtual Training/Meeting Platform, Virtual Engagement Workshops, Emotional Intelligence Workshops, and Situational Leadership Training.
- Global Partnerships: Strategized with various regional department heads to develop customized programs that lead to increased sales and productivity of the field force.
- Executed Amgen Canada’s first virtual product launch and virtual national sales meeting.
Senior Biopharmaceutical Rep. Cardio Bone
Amgen Canada
Toronto East, Ontario
11.2017 - 03.2020
- Exceeded sales objectives: Within the cardiovascular and osteoporotic biologic space, to physicians, pharmacists, and other key health care professionals.
- Combined sales of Repatha and Prolia ranked third nationally in 2018.
- Repatha Sales: 2019: YTD 114%, growth at 180%, and 109% per cycle.
- Prolia Sales: 2019: YTD 96% growth at 20%.
- Evenity sales: Placed in the top 10 territories for enrollments after the product launch.
Cardiovascular Medical Representative
Servier Canada
Downtown Toronto, Ontario
05.2010 - 11.2017
- Exceptional Customer Service: Drove adoption of Cardiovascular and Metabolic products (Coversyl, Diamicron, Lixiana) to key health care professionals by building trust and collaboration through successful implementation of patient programs, Phase IV trials, and CMEs within the territory.
- Exceeded Sales and Growth Objectives: 2011, 2013, 2015, 2016, and 2017 through development and execution of a strategic territory business plan, customized implementation of four Phase IV trials, and strong cross-functional partnership with various stakeholders.
- Product Launches: Top 10 placement for Viacoram (2016, nationally) and 7th place for Lixiana (2017, nationally).
Education
Specialized Honors - Kinesiology & Health Sciences
York University
06.2009
Skills
- Team Leadership
- Solution Selling
- National Account Management
- Cross-Functional Collaboration
- Contract Negotiations
- Relationship Building
- Strategic Planning
- Forecasting
- Business Development
- Customer Engagement
- Market and Competitive Analysis
- Coaching and Mentoring
- Workshop Development
- Sales Training
- Strong Communication
Accomplishments
- Valeo Pharma Awarded MVP: 2021
- Servier Canada Awarded MVP: 2014,2016,2017
- Servier Canada Award of Excellence (SAX Club) 2013 and 2016 (Most improved Territory and Region of the year and GP Territory of the Year).
- Amgen: Orchestrated and established Michael Garron Hospital’s first and only Post-Fracture Care Procedure.
Extended Projects
Valeo Pharma: Co-developed a patient injection video in collaboration with Toronto Grace Salvation Army Hospital, enhancing patient continuity of care.
Amgen: Designated as Ontario Regional Canadian Healthcare Compliance Lead, Regional Technology Analytics Team Lead for CRM, S1 National Sales Meeting Lead, Regional Mentor, and National Lead for the Sales/Marketing Intelligence Team.
Servier: Regional IT and Marketing Field Intelligence Team for the Business Unit.
Affiliations
- Authentic Church: Online Crew
- Fitness
- Travel
- Baking
Timeline
National Sales Director
Valeo Pharma
05.2022 - Current
Key Account Manager
Valeo Pharma
02.2021 - 05.2022
Global Learning & Performance Manager
Amgen Canada
03.2020 - 02.2021
Senior Biopharmaceutical Rep. Cardio Bone
Amgen Canada
11.2017 - 03.2020
Cardiovascular Medical Representative
Servier Canada
05.2010 - 11.2017
Specialized Honors - Kinesiology & Health Sciences
York University
Similar Profiles
Donna KuzminskiDonna Kuzminski
Key Account Manager, Hospital Division, Hematology - Biosimilars at Valeo PharmaKey Account Manager, Hospital Division, Hematology - Biosimilars at Valeo Pharma
Camille Maharajh-BoisselleCamille Maharajh-Boisselle
Key Account Manager at Valeo Pharma Inc.Key Account Manager at Valeo Pharma Inc.
Sachin CHANDELKERSachin CHANDELKER
Electronics Design Engineer at Valeo Systèmes De Contrôle Moteur & Valeo IndiaElectronics Design Engineer at Valeo Systèmes De Contrôle Moteur & Valeo India